Vanguard Capital Management
NUVB icon

Vanguard Capital Management’s Nuvation Bio NUVB Stock Holding History

Vanguard Capital Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67.7M Buy
11,919,514
+293,316
+3% +$1.43M ﹤0.01% 1773
2026
Q1 		$49.9M Buy
+11,626,198
New +$64.8M ﹤0.01% 1850

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Vanguard Capital Management's NUVB Position: Q2 2026 in Review

Vanguard Capital Management increased its Nuvation Bio (NUVB) stake by 2.5% in Q2 2026, buying an estimated $1.43M and bringing the position to 11,919,514 shares worth $67.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1773.

Vanguard Capital Management first reported a position in NUVB in Q1 2026 and has held it in 2 quarters since. 242 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Vanguard Capital Management held 11,919,514 shares of Nuvation Bio worth $67.7M as of Q2 2026.
  • Vanguard Capital Management bought 293,316 Nuvation Bio shares in Q2 2026, an estimated $1.43M.
  • Nuvation Bio made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #1773 holding.
  • Vanguard Capital Management first reported a position in Nuvation Bio in Q1 2026 and has held it in 2 quarters since.
  • 242 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.